***Upcoming Changes to Cayuse:
Initial Submission Template – Effective Monday, November 3rd
Research Compliance and Regulatory Programs is pleased to announce several changes to the initial application in an effort to simplify the IRB submission process, going into effect on Monday November 3rd:
- Removal of benign behavioral intervention (BBI) section and expanded use of prospective agreement form for all exempt studies
- Ability to review exempt and expedited review categories
- Streamlining of questions throughout application to reduce redundancies between sections
- Addition of consent check-box selection to allow for an alteration of the consent process that includes oral consent, requesting a waiver of consent, or a waiver of documentation of consent, if appropriate
- Re-ordering of sections to streamline the review process and ensure the appropriate regulations are applied depending on the funding agency
How will the changes be reflected?
The application will look largely the same. Under the Study Design section, investigators will now be prompted to indicate if their study is no greater than minimal risk. If this is indicated as yes, investigators will see a list of the exempt categories with definitions and an infographic to help investigators determine if their study falls within an exemption category. If investigators do not believe that their project fits into an exempt category, they will be prompted to view the expedited categories.
Studies that do not meet the criteria for either exempt or expedited review will be assigned to an upcoming convened board meeting. Please see our posted Review Schedule for full board meeting dates.
Why were these changes made?
These changes were made to expand the use of the prospective agreement form in place of a standard informed consent. All studies that are deemed to be exempt will now be eligible to use this form to simplify the consent process. The BBI section has been removed from the application as it caused confusion and led to more returned submissions. It is our intention that by viewing the exempt and expedited categories, investigators will be able to better ascertain what level of privacy and confidentiality is necessary for their study. Templates for both prospective agreement and informed consent forms can be found here.
What else has changed?
Please also note that in July of this year, Dr. Sarah Kelly took over as the IRB Chair. Her name and contact information should be listed in all consent, assent, and prospective agreement forms going forward. Please find her information in our updated consent templates. For active protocols approved prior to the Chair change, IRB Chair information should be updated via Modification submission at the Investigator’s soonest convenience.
Any investigators with questions or concerns regarding these changes to the IRB Initial submission process should send an email to: reviewboard@montclair.edu.
Welcome to Cayuse, our eIRB system
Only full-time tenured and tenure-track faculty and eligible full-time professional staff may serve as Principal Investigators. Research team members named on protocols must be current Montclair employees or actively enrolled students. ALL Montclair State University students and new employees will need to request an IRB account by clicking the “Request a Cayuse Account” button above to gain access to Cayuse.
Note: All new faculty, staff and students need to request an account to be able to sign into Cayuse IRB.
If you have any questions about Cayuse IRB, please contact reviewboard@montclair.edu.
For assistance troubleshooting in Cayuse, please view our resources here.